Alkermes (ALKS) Inventory Average (2011 - 2026)
Alkermes (ALKS) posted quarterly Inventory Average of $317.8 million for Q2 2026, up 69.35% year-over-year from $187.7 million in Q2 2025, and up 19.19% quarter-over-quarter from $266.7 million in Q1 2026.
Alkermes (ALKS) Inventory Average (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Inventory Average for 16 consecutive years, with $317.8 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Inventory Average rose 69.35% year-over-year to $317.8 million; the TTM figure through Jun 2026 stood at $317.8 million (up 69.35% YoY), while the FY2025 annual figure was $189.8 million, up 2.77% from the prior year.
- Inventory Average climbed to $317.8 million in Q2 2026 per ALKS's latest filing, from $266.7 million in the prior quarter.
- Across five years, Inventory Average topped out at $317.8 million in Q2 2026 and bottomed at $152.6 million in Q1 2022.
- Historically, Inventory Average has averaged $194.6 million across 5 years, with a median of $188.5 million in 2023.
- Annual changes were most pronounced in 2025 — Inventory Average fell 4.8% — and 2026, when it soared 69.35%.
- Alkermes' Inventory Average stood at $173.9 million in 2022, then advanced by 8.88% to $189.3 million in 2023, then declined by 1.22% to $187.0 million in 2024, then increased by 3.65% to $193.8 million in 2025, then soared by 63.99% to $317.8 million in 2026.
- Business Quant data shows ALKS's Inventory Average at $317.8 million in Q2 2026, $266.7 million in Q1 2026, and $193.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 824.00 Mn |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | 317.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 317.83 Mn |
| Mar 31, 2026 | 266.66 Mn |
| Dec 31, 2025 | 193.81 Mn |
| Sep 30, 2025 | 191.46 Mn |
| Jun 30, 2025 | 187.68 Mn |
| Mar 31, 2025 | 183.16 Mn |
| Dec 31, 2024 | 186.99 Mn |
| Sep 30, 2024 | 192.91 Mn |
| Jun 30, 2024 | 196.55 Mn |
| Mar 31, 2024 | 192.39 Mn |
| Dec 31, 2023 | 189.30 Mn |
| Sep 30, 2023 | 190.78 Mn |
| Jun 30, 2023 | 187.18 Mn |
| Mar 31, 2023 | 183.20 Mn |
| Dec 31, 2022 | 173.86 Mn |
| Sep 30, 2022 | 160.95 Mn |
| Jun 30, 2022 | 155.20 Mn |
| Mar 31, 2022 | 152.56 Mn |
| Dec 31, 2021 | 144.52 Mn |
| Sep 30, 2021 | 137.39 Mn |